Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute renal dysfunction associated with selective COX-2 inhibitor therapy.

D Papaioannides1, C Bouropoulos, D Sinapides

  • 1Department of Medicine and Urology, Arta General Hospital, Greece.

International Urology and Nephrology
|November 28, 2002
PubMed
Summary

Selective COX-2 inhibitors reduce gastrointestinal issues but can cause kidney damage. This case highlights reversible acute renal failure from rofecoxib in an elderly patient, emphasizing cautious use in those with NSAID-related risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leadless pacing: First experience and outcomes in an isolated area in the setting of the Greek financial crisis.

Hippokratia·2022
Same author

Preeclampsia and long-term coronary artery disease: How to minimize the odds?

European journal of obstetrics, gynecology, and reproductive biology·2020
Same author

The association of hematological indices with the response to cardiac resynchronization therapy: a single-center study.

Hippokratia·2020
Same author

Impact of baseline renal function on all-cause mortality in patients who underwent cardiac resynchronization therapy: A systematic review and meta-analysis.

Journal of arrhythmia·2017
Same author

Diagnosis of neurobrucellosis in resource-limited real-world settings: A case-series of 8 patients.

Journal of the neurological sciences·2017
Same author

Iron complex, dabigatran and toxic epidermal necrolysis syndrome: a case-report.

Journal of clinical pharmacy and therapeutics·2012

Area of Science:

  • Nephrology
  • Pharmacology

Background:

  • Selective cyclooxygenase-2 (COX-2) inhibitors offer reduced gastrointestinal (GI) adverse effects compared to traditional nonselective nonsteroidal anti-inflammatory drugs (NSAIDs).
  • The potential for nephrotoxicity with selective COX-2 inhibitors remains less understood.
  • Elderly patients and those with pre-existing risk factors are particularly vulnerable to NSAID-induced kidney injury.

Observation:

  • A case study involving an elderly patient treated with rofecoxib, a selective COX-2 inhibitor.
  • The patient presented with several risk factors typically associated with traditional NSAID-related nephrotoxicity.
  • Acute renal failure was observed during the course of rofecoxib treatment.

Findings:

  • The patient experienced reversible acute renal failure attributed to rofecoxib therapy.

Related Experiment Videos

  • This suggests that selective COX-2 inhibitors, despite their GI safety profile, can pose a risk of kidney damage.
  • Prostaglandin-dependent renal function is a key factor in NSAID-induced nephrotoxicity.

    • Implications:

    • Therapy with selective COX-2 inhibitors requires a cautious approach, particularly in patients with risk factors for NSAID-related nephrotoxicity.
    • Monitoring renal function is crucial for patients receiving selective COX-2 inhibitors, especially those with predisposing conditions.
    • Further research is needed to fully elucidate the nephrotoxic potential of selective COX-2 inhibitors across diverse patient populations.